finasteride and Bone Cancer

finasteride has been researched along with Bone Cancer in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Das, K; Lim, D; Lorena, PD; Ng, LK; Reichardt, JK; Salto-Tellez, M; Shen, L; Siow, WY; Teh, M	1
Bittmann, L; Brufsky, A; Kantoff, PW; Kaplan, ID; Kaufman, DS; Manola, J; Oh, WK; Smith, MR	1

Trials

1 trial(s) available for finasteride and Bone Cancer

Article	Year
Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up. Urology, 2003, Volume: 62, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Androgen Antagonists; Androgens; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Disease Progression; Drug Resistance, Neoplasm; Enzyme Inhibitors; Finasteride; Flutamide; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Salvage Therapy; Survival Rate; Treatment Outcome	2003

Article

Year

Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up.

Urology, 2003, Volume: 62, Issue:1

Topics: Adenocarcinoma; Adult; Aged; Androgen Antagonists; Androgens; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Disease Progression; Drug Resistance, Neoplasm; Enzyme Inhibitors; Finasteride; Flutamide; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Salvage Therapy; Survival Rate; Treatment Outcome

2003

Other Studies

1 other study(ies) available for finasteride and Bone Cancer

Article	Year
Differential expression of steroid 5alpha-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer. Endocrine-related cancer, 2010, Volume: 17, Issue:3 Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Angiogenic Proteins; Azasteroids; Biomarkers, Tumor; Blotting, Western; Bone Neoplasms; Cell Nucleus; Cell Proliferation; Dutasteride; Enzyme-Linked Immunosorbent Assay; Finasteride; Gene Expression Profiling; Humans; Immunoenzyme Techniques; Isoenzymes; Lymphatic Metastasis; Male; Membrane Proteins; Middle Aged; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Array Analysis; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A	2010

Article

Year

Differential expression of steroid 5alpha-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer.

Endocrine-related cancer, 2010, Volume: 17, Issue:3

Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Angiogenic Proteins; Azasteroids; Biomarkers, Tumor; Blotting, Western; Bone Neoplasms; Cell Nucleus; Cell Proliferation; Dutasteride; Enzyme-Linked Immunosorbent Assay; Finasteride; Gene Expression Profiling; Humans; Immunoenzyme Techniques; Isoenzymes; Lymphatic Metastasis; Male; Membrane Proteins; Middle Aged; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Array Analysis; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2010